Xconomy Texas — San Antonio — Most research institutions or universities have at least one success story, a medicine or therapy developed there that made a big impact. Some have many.
For the Oklahoma Medical Research Foundation, a 70-year-old nonprofit biomedical-focused institute with 56 researchers on staff based in Oklahoma City, OK, what first comes to mind is Alexion and its blockbuster monoclonal antibody treatment, Solaris. Alexion (NASDAQ: ALXN) is a New Haven, CT-based company and researchers at the Oklahoma foundation made scientific discoveries that led to the development of Solaris, a treatment for rare disorders, says Stephen Prescott, president of the foundation.
Image: http://www.xconomy.com
